Self-monitoring Blood Glucose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Settings, and Diagnostic Centers), By Region and Competition, 2020-2030F

August 2025 | 188 pages | ID: SEB7A5628F5BEN
TechSci Research

Abstracts

Market Overview

Global Self-monitoring Blood Glucose Market has valued at USD 10.28 Billion in 2024 and is expected to reach USD 16.87 billion by 2030 with a CAGR of 8.61% during the forecast period. Blood glucose monitoring plays a crucial role in empowering diabetic patients to make informed daily management decisions regarding food intake, insulin dosage and physical exercise. Self-monitoring blood glucose (SMBG) represents a contemporary diabetes management procedure that entails the use of blood glucose meters by patients to quickly check their glucose levels and obtain accurate measurements of capillary glucose concentration. SMBG technology, encompassing test strips, lancets, and blood glucose meters, facilitates long-term glycemic control. By analyzing readings, individuals can adjust treatment, evaluate the impact of antidiabetics and stress management, and make informed decisions regarding diet, insulin dosage, and physical exercise, among other factors. This comprehensive process involves the utilization of test strips, lancets, and blood glucose meters to achieve sustained glycemic control.

Key Market Drivers

High Prevalence of Diabetes

The increase in the geriatric population and the high prevalence of diabetes, along with the rising risk factors associated with diabetes, are key drivers for the growth of the self-monitoring of blood glucose (SMBG) market. Furthermore, government initiatives aimed at raising awareness among the population also contribute to the market's growth. However, it should be noted that the devices do not measure the exact level of glucose in the blood, which can result in inaccurate results. Moreover, the lack of reimbursement and stringent regulations for these devices may hinder the overall market growth. Nevertheless, there are untapped opportunities in emerging markets, and the growing awareness about diabetes monitoring devices is expected to generate new prospects within the forecast period. However, challenges such as the lack of patient awareness and the high cost of advanced devices and accessories are projected to impede the market's growth.

Key Market Challenges

Compliance and Adherence

Regular and consistent blood glucose monitoring is essential for effective diabetes management. However, some individuals may struggle with adherence, either due to forgetfulness, discomfort associated with testing, or a lack of motivation. Properly using self-monitoring blood glucose devices requires some level of technical skill and knowledge. Some elderly individuals or those with limited dexterity may find it challenging to operate the devices correctly. Self-monitoring blood glucose devices need to be accurately calibrated and maintained to provide reliable results. Incorrect calibration or using expired test strips can lead to inaccurate readings.

Key Market Trends

New Product Launches in the Market

Prominent companies operating in the self-monitoring blood glucose (SMBG) devices market are strategically focused on developing innovative technological solutions to enhance their market position. For instance, in August 2022, Intuity Medical, Inc., a commercial-stage medical technology and digital health company committed to simplifying life with diabetes, introduced the POGO Automatic® Blood Glucose Monitoring System at over 2,200 US pharmacies operated by Kroger Health, the healthcare division of The Kroger Co. The POGO Automatic from Intuity Medical is the sole FDA-approved automatic blood glucose monitor featuring 10-test cartridge technology, eliminating the need for individuals with diabetes to carry or load separate lancets and test strips. It effortlessly lances, collects blood, and provides a glucose result with just a touch of a button.

Key Market Players

• Abbott Laboratories
• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care
• Dexcom, Inc.
• Sanofi
• Novo Nordisk
• Insulet Corporation
• Ypsomed Holdings
• Glysens Incorporated

Report Scope:

In this report, the Global Self-monitoring Blood Glucose Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Self-monitoring Blood Glucose Market, By Product:
• Self-monitoring Blood Glucose Meters
• Continuous Glucose Monitors
• Testing Strips
• Lancets
• Self-monitoring Blood Glucose Market, By Application:
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Self-monitoring Blood Glucose Market, By End User:
• Hospitals
• Home Settings,
• Diagnostic Centers
• Self-monitoring Blood Glucose Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Self-monitoring Blood Glucose Market.

Available Customizations:

Global Self-monitoring Blood Glucose market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. VOICE OF CUSTOMER

5. GLOBAL SELF-MONITORING BLOOD GLUCOSE MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets)
  5.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
  5.2.3. By End User (Hospitals, Home Settings, and Diagnostic Centres)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Application
  6.2.3. By End User
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Self-monitoring Blood Glucose Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By Application
      6.3.1.2.3. By End User
  6.3.2. Canada Self-monitoring Blood Glucose Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By Application
      6.3.2.2.3. By End User
  6.3.3. Mexico Self-monitoring Blood Glucose Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By Application
      6.3.3.2.3. By End User

7. EUROPE SELF-MONITORING BLOOD GLUCOSE MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Application
  7.2.3. By End User
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Self-monitoring Blood Glucose Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Application
      7.3.1.2.3. By End User
  7.3.2. United Kingdom Self-monitoring Blood Glucose Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Application
      7.3.2.2.3. By End User
  7.3.3. Italy Self-monitoring Blood Glucose Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Application
      7.3.3.2.3. By End User
  7.3.4. France Self-monitoring Blood Glucose Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Application
      7.3.4.2.3. By End User
  7.3.5. Spain Self-monitoring Blood Glucose Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Application
      7.3.5.2.3. By End User

8. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Application
  8.2.3. By End User
  8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
  8.3.1. China Self-monitoring Blood Glucose Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Application
      8.3.1.2.3. By End User
  8.3.2. India Self-monitoring Blood Glucose Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Application
      8.3.2.2.3. By End User
  8.3.3. Japan Self-monitoring Blood Glucose Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Application
      8.3.3.2.3. By End User
  8.3.4. South Korea Self-monitoring Blood Glucose Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Application
      8.3.4.2.3. By End User
  8.3.5. Australia Self-monitoring Blood Glucose Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Application
      8.3.5.2.3. By End User

9. SOUTH AMERICA SELF-MONITORING BLOOD GLUCOSE MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Application
  9.2.3. By End User
  9.2.4. By Country
9.3. South America: Country Analysis
  9.3.1. Brazil Self-monitoring Blood Glucose Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Application
      9.3.1.2.3. By End User
  9.3.2. Argentina Self-monitoring Blood Glucose Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Application
      9.3.2.2.3. By End User
  9.3.3. Colombia Self-monitoring Blood Glucose Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Application
      9.3.3.2.3. By End User

10. MIDDLE EAST AND AFRICA SELF-MONITORING BLOOD GLUCOSE MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Application
  10.2.3. By End User
  10.2.4. By Country
10.3. MEA: Country Analysis
  10.3.1. South Africa Self-monitoring Blood Glucose Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Application
      10.3.1.2.3. By End User
  10.3.2. Saudi Arabia Self-monitoring Blood Glucose Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Application
      10.3.2.2.3. By End User
  10.3.3. UAE Self-monitoring Blood Glucose Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Application
      10.3.3.2.3. By End User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

13. GLOBAL SELF-MONITORING BLOOD GLUCOSE MARKET: SWOT ANALYSIS

14. COMPETITIVE LANDSCAPE

14.1. Abbott Laboratories
  14.1.1. Business Overview
  14.1.2. Company Snapshot
  14.1.3. Products & Services
  14.1.4. Financials (As Reported)
  14.1.5. Recent Developments
  14.1.6. Key Personnel Details
  14.1.7. SWOT Analysis
14.2. Medtronic plc
14.3. F. Hoffmann-La Roche Ltd
14.4. Ascensia Diabetes Care
14.5. Dexcom, Inc.
14.6. Sanofi
14.7. Novo Nordisk
14.8. Insulet Corporation
14.9. Ypsomed Holdings
14.10. Glysens Incorporated

15. STRATEGIC RECOMMENDATIONS

16. ABOUT US & DISCLAIMER